In a major breakthrough for the field of biomedical engineering, a team of researchers from the University of Melbourne has successfully devised a fast, cost-effective, and scalable technique to engineer blood vessels using natural tissue. Co-led by Associate Professor Daniel Heath and Professor Andrea O'Connor, the study pioneers a novel approach to 'tissue engineering' blood vessels, opening up promising possibilities for cardiovascular disease treatment. Findings from this study were published recently in ACS Applied Materials and Interfaces. 

The researchers leveraged a combination of cutting-edge materials and fabrication technologies to create blood vessels with intricate geometries closely resembling native blood vessels. This advancement is of critical significance as blood vessels play a crucial role in sustaining life by transporting oxygen-rich blood and essential nutrients throughout the body while eliminating harmful waste products. Dysfunction in blood vessels can lead to life-threatening disorders such as heart attacks, strokes, and aneurysms, making cardiovascular disease the leading cause of global mortality.

According to Associate Professor Heath, blood vessel tissue engineering has been a longstanding pursuit of researchers worldwide, but existing methods have been fraught with challenges. “Current methods are slow, require specialized and expensive equipment like bioreactors, and are low throughput—meaning it’s difficult to provide the needed supply of engineered vessels,” he remarked.

“By combining multiple materials and fabrication technologies, our method brings us closer to a future where engineered blood vessels will become a transformative solution for cardiovascular disease, especially for those patients who lack suitable donor vessels.”

While bypass surgery has been a life-saving alternative for replacing severely damaged blood vessels, it has limitations, especially for smaller-diameter blood channels like the coronary artery. Non-living synthetic grafts can lead to blood clotting and obstruction, rendering them unsuitable in certain situations. Consequently, patients with limited options due to previous surgery or comorbidities like diabetes face significant challenges.

To overcome these limitations, the researchers focused on developing 'tissue-engineered' blood vessels using human cells and tissues. These engineered vessels hold immense potential not only in treating cardiovascular illness but also in constructing integrated blood supplies for larger tissue creations.

Professor O'Connor expressed excitement about the progress achieved in engineering human blood vessels noting that “we are now able to rapidly and cheaply manufacture blood vessels using living tissue that has appropriate mechanical properties and mimics the cellular orientation of the inner-most layer of blood vessels.”

“While the engineered blood vessels are not yet ready for bypass surgery, the findings mark a significant advancement in the field of tissue engineering.”

The potential impact of this research on cardiovascular disease management is immense, offering hope for countless patients worldwide who suffer from life-threatening conditions. With this pioneering work, the University of Melbourne researchers have propelled the field of tissue engineering into a promising future, where engineered blood vessels may hold the key to saving lives and revolutionizing cardiovascular medicine.

‍